You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 12, November 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  Hypertension
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

A Screening Test to Identify Aldosterone-Producing Adenoma by Measuring Plasma Renin Activity

Results in Hypertensive Patients

Kunihide Hiramatsu, MD; Takashi Yamada, MD; Yaichiro Yukimura, MD; Ichiro Komiya, MD; Kazuo Ichikawa, MD; Masaki Ishihara, MD; Hajime Nagata, MD; Tomio Izumiyama, MD

Arch Intern Med. 1981;141(12):1589-1593.


Abstract

• In an attempt to devise a screening test for aldosterone-producing adenoma (APA) among hypertensive patients, the serum sodium and potassium levels, plasma renin activity (PRA), plasma aldosterone concentration, and aldosterone-PRA ratio were measured in 348 patients with hypertension. Nine patients with a substantially elevated aldosterone-PRA ratio were selected and hospitalized for further investigations. All nine patients were then recognized by scintigraphy with labeled cholesterol, venography, and surgical excision as having APA. The serum concentration of potassium was subnormal in three of nine patients with APA. In patients with APA, administration of diuretics and salt restriction significantly elevated PRA. However, even under notable diurnal and day-to-day variations of plasma aldosterone concentrations, the aldosterone-PRA ratio was always elevated inappropriately (more than 400) in patients with APA. In contrast, after administration of diuretics, both the PRA and aldosterone levels increased significantly in patients with essential hypertension, but the aldosterone-PRA ratio was less than 200. Since the renin-angiotensin system seems to be a major factor controlling aldosterone secretion in normal subjects, it is suggested that an elevation of aldosterone-PRA ratio more than 400 is a useful screening tool for the prediction of APA among hypertensive patients.

(Arch Intern Med 1981;141:1589-1593)



Author Affiliations

From the Department of Medicine, Institute of Adaptation Medicine, School of Medicine, Shinshu University, Matsumoto, Japan (Drs Hiramatsu, Yukimura, Komiya, Ichikawa, and Ishihara); and the Department of Medicine, Hokushin General Hospital, Nakano-shi, Nagano-ken, Japan (Drs Yamada, Nagata, and Izumiyama).


Footnotes

Accepted for publication Oct 14, 1980.

Reprint requests to Department of Medicine, Institute of Adaptation Medicine, School of Medicine, Shinshu University, Matsumoto, Japan (Dr Yamada).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How Little Aldosterone is Able to Raise Blood Pressure?
Ritz
CJASN 2009;4:703-710.
FULL TEXT  

Adrenal incidentaloma: evaluation and management
Singh and Buch
J. Clin. Pathol. 2008;61:1168-1173.
ABSTRACT | FULL TEXT  

Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Funder et al.
J. Clin. Endocrinol. Metab. 2008;93:3266-3281.
ABSTRACT | FULL TEXT  

Primary aldosteronism and aldosterone-associated hypertension
Rayner
J. Clin. Pathol. 2008;61:825-831.
ABSTRACT | FULL TEXT  

Is There an Unrecognized Epidemic of Primary Aldosteronism? (Con)
Kaplan and Calhoun
Hypertension 2007;50:454-458.
FULL TEXT  

Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma
Rossi et al.
Hypertension 2007;50:424-431.
ABSTRACT | FULL TEXT  

The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio
Hood et al.
Circulation 2007;116:268-275.
ABSTRACT | FULL TEXT  

Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
Umpierrez et al.
Diabetes Care 2007;30:1699-1703.
ABSTRACT | FULL TEXT  

Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
Schirpenbach et al.
Eur J Endocrinol 2006;154:865-873.
ABSTRACT | FULL TEXT  

Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful
Daunt
RadioGraphics 2005;25:S143-S158.
ABSTRACT | FULL TEXT  

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez et al.
J Am Coll Cardiol 2005;45:1243-1248.
ABSTRACT | FULL TEXT  

Screening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin Activity
Schwartz and Turner
Clin. Chem. 2005;51:386-394.
ABSTRACT | FULL TEXT  

The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling
Tiu et al.
J. Clin. Endocrinol. Metab. 2005;90:72-78.
ABSTRACT | FULL TEXT  

Review: Aldosterone -- the future challenge in cardiovascular disease?
Connell
British Journal of Diabetes & Vascular Disease 2004;4:370-376.
ABSTRACT  

Aldosterone-Renin Ratios in the Context of Primary Care
Funder
J. Clin. Endocrinol. Metab. 2004;89:4219-4220.
FULL TEXT  

Aldosterone to Renin Ratio in a Primary Care Setting: The Bussolengo Study
Olivieri et al.
J. Clin. Endocrinol. Metab. 2004;89:4221-4226.
ABSTRACT | FULL TEXT  

Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development: A Possible Role for Angiotensin-Converting Enzyme and the Receptors for Angiotensin II and Aldosterone
Keidar et al.
Circulation 2004;109:2213-2220.
ABSTRACT | FULL TEXT  

Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension
Plouin et al.
Nephrol Dial Transplant 2004;19:774-777.
FULL TEXT  

Variability in the Renin/Aldosterone Profile under Random and Standardized Sampling Conditions in Primary Aldosteronism
Tanabe et al.
J. Clin. Endocrinol. Metab. 2003;88:2489-2494.
ABSTRACT | FULL TEXT  

Minireview: Primary Aldosteronism--Changing Concepts in Diagnosis and Treatment
Young
Endocrinology 2003;144:2208-2213.
ABSTRACT | FULL TEXT  

Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun et al.
Hypertension 2002;40:892-896.
ABSTRACT | FULL TEXT  

Variation at the Aldosterone Synthase (CYP11B2) Locus Contributes to Hypertension in Subjects with a Raised Aldosterone-to-Renin Ratio
Lim et al.
J. Clin. Endocrinol. Metab. 2002;87:4398-4402.
ABSTRACT | FULL TEXT  

Diagnostic Value of the Post-Captopril Test in Primary Aldosteronism
Castro et al.
Hypertension 2002;39:935-938.
ABSTRACT | FULL TEXT  

Hyperaldosteronism: recent concepts, diagnosis, and management
Foo et al.
Postgrad. Med. J. 2001;77:639-644.
FULL TEXT  

Review: Diagnosis and management of primary aldosteronism
Stowasser et al.
Journal of Renin-Angiotensin-Aldosterone System 2001;2:156-169.
 

Performance of the Basal Aldosterone to Renin Ratio and of the Renin Stimulation Test by Furosemide and Upright Posture in Screening for Aldosterone-Producing Adenoma in Low Renin Hypertensives
Hirohara et al.
J. Clin. Endocrinol. Metab. 2001;86:4292-4298.
ABSTRACT | FULL TEXT  

Captopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism
Agharazii et al.
Hypertension 2001;37:1440-1443.
ABSTRACT | FULL TEXT  

Primary Hyperaldosteronism without Suppressed Renin Due to Secondary Hypertensive Kidney Damage
Oelkers et al.
J. Clin. Endocrinol. Metab. 2000;85:3266-3270.
ABSTRACT | FULL TEXT  

Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore
Loh et al.
J. Clin. Endocrinol. Metab. 2000;85:2854-2859.
ABSTRACT | FULL TEXT  

Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology
Fardella et al.
J. Clin. Endocrinol. Metab. 2000;85:1863-1867.
ABSTRACT | FULL TEXT  

Lys173Arg and -344T/C Variants of CYP11B2 in Japanese Patients With Low-Renin Hypertension
Komiya et al.
Hypertension 2000;35:699-703.
ABSTRACT | FULL TEXT  

Primary Aldosteronism
Ganguly
NEJM 1998;339:1828-1834.
FULL TEXT  

Familial Hyperaldosteronism Type II: Description of a Large Kindred and Exclusion of the Aldosterone Synthase (CYP11B2) Gene
Torpy et al.
J. Clin. Endocrinol. Metab. 1998;83:3214-3218.
ABSTRACT | FULL TEXT  

Primary aldosteronism and its variants
Gomez-Sanchez
Cardiovasc Res 1998;37:8-13.
FULL TEXT  

Reduced Renal Extraction of Atrial Natriuretic Peptide in Primary Aldosteronism
Tunny et al.
Hypertension 1995;26:624-627.
ABSTRACT | FULL TEXT  

The Diagnosis of Primary Aldosteronism and Separation of Two Major Subtypes
Weinberger and Fineberg
Arch Intern Med 1993;153:2125-2129.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.